HSDT Profile
Helius Medical Technologies, Inc., headquartered in Newtown, Pennsylvania, is a pioneering neurotechnology company dedicated to advancing non-invasive therapies for neurological disorders and injuries. Established with a focus on innovation, the company specializes in the development, licensing, and acquisition of cutting-edge technologies designed to alleviate symptoms associated with neurological diseases and trauma.
At the forefront of its product portfolio is the Portable Neuromodulation Stimulator (PoNS), a revolutionary non-surgical medical device. PoNS is specifically engineered for short-term treatment of gait deficits stemming from symptoms of multiple sclerosis and balance deficits resulting from mild-to-moderate traumatic brain injury. When used in conjunction with supervised therapeutic exercise, PoNS aims to enhance neuroplasticity and improve motor functions, offering patients a potential pathway to enhanced mobility and quality of life.
Helius Medical Technologies continues to expand its reach through strategic partnerships and ongoing research initiatives aimed at broadening the therapeutic applications of PoNS and other emerging technologies. The company collaborates with healthcare providers, researchers, and regulatory bodies to validate and commercialize innovative solutions that address unmet medical needs in the neurological space.
Driven by a commitment to scientific rigor and patient-centric care, Helius Medical Technologies remains dedicated to pioneering advancements in neurorehabilitation. With a vision to redefine treatment paradigms through technological innovation, the company strives to empower healthcare practitioners and improve outcomes for individuals affected by neurological conditions worldwide.
|
